Literature DB >> 12791928

Francisella tularensis bacteremia.

X Haristoy1, A Lozniewski, C Tram, D Simeon, L Bevanger, C Lion.   

Abstract

Bacteremia caused by Francisella tularensis is rare and has been reported mainly in the United States and infrequently in Europe. We report herein the first case of bacteremic F. tularensis pneumonia in an immunocompetent individual in southern Europe.

Entities:  

Mesh：

Year:  2003        PMID： 12791928      PMCID： PMC156490          DOI： 10.1128/JCM.41.6.2774-2776.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  28 in total

1.  Francisella philomiragia comb. nov. (formerly Yersinia philomiragia) and Francisella tularensis biogroup novicida (formerly Francisella novicida) associated with human disease.

Authors:  D G Hollis; R E Weaver; A G Steigerwalt; J D Wenger; C W Moss; D J Brenner
Journal:  J Clin Microbiol       Date:  1989-07       Impact factor: 5.948

2.  Identification of Francisella species and discrimination of type A and type B strains of F. tularensis by 16S rRNA analysis.

Authors:  M Forsman; G Sandström; B Jaurin
Journal:  Appl Environ Microbiol       Date:  1990-04       Impact factor: 4.792

Review 3.  Tularemia as a biological weapon: medical and public health management.

Authors:  D T Dennis; T V Inglesby; D A Henderson; J G Bartlett; M S Ascher; E Eitzen; A D Fine; A M Friedlander; J Hauer; M Layton; S R Lillibridge; J E McDade; M T Osterholm; T O'Toole; G Parker; T M Perl; P K Russell; K Tonat
Journal:  JAMA       Date:  2001-06-06       Impact factor: 56.272

4.  Isolation of Francisella tularensis from blood.

Authors:  J M Provenza; S A Klotz; R L Penn
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

5.  Rapid laboratory diagnosis of ulceroglandular tularemia with polymerase chain reaction.

Authors:  E K Karhukorpi; J Karhukorpi
Journal:  Scand J Infect Dis       Date:  2001

6.  Isolation of Francisella tularensis biovar palaearctica from human blood.

Authors:  A Tärnvik; C Henning; E Falsen; G Sandström
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-02       Impact factor: 3.267

7.  Enhancing recovery of Francisella tularensis from blood.

Authors:  B W Reary; S A Klotz
Journal:  Diagn Microbiol Infect Dis       Date:  1988-10       Impact factor: 2.803

8.  Competitive enzyme immunoassay for antibodies to a 43,000-molecular-weight Francisella tularensis outer membrane protein for the diagnosis of tularemia.

Authors:  L Bevanger; J A Maeland; A I Naess
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

9.  Opportunistic infections in chronic lymphocytic leukemia.

Authors:  W Fulkerson; A Spickard; B W Davis
Journal:  South Med J       Date:  1979-11       Impact factor: 0.954

10.  Tularemia and rhabdomyolysis.

Authors:  A B Kaiser; D Rieves; A H Price; M R Gelfand; R E Parrish; M D Decker; M E Evans
Journal:  JAMA       Date:  1985-01-11       Impact factor: 56.272
View more
  11 in total

1.  A case of tularemia after an endurance run in a non-endemic region.

Authors:  R Meckenstock; A Therby; A Le Monnier; D Khau; S Monnier; B Pangon; A Greder-Belan
Journal:  Infection       Date:  2012-10-17       Impact factor: 3.553

2.  The class A β-lactamase FTU-1 is native to Francisella tularensis.

Authors:  Nuno T Antunes; Hilary Frase; Marta Toth; Sergei B Vakulenko
Journal:  Antimicrob Agents Chemother       Date:  2011-11-14       Impact factor: 5.191

3.  First case report of post-operative infection due to Francisella tularensis after cardiac surgery.

Authors:  Arif Maqsood Ali; Muhammad Noor Ul Amin; Shazia Arif
Journal:  Access Microbiol       Date:  2019-06-14

4.  Complete genome sequence of Francisella tularensis subspecies holarctica FTNF002-00.

Authors:  Ravi D Barabote; Gary Xie; Thomas S Brettin; Steven H Hinrichs; Paul D Fey; Justin J Jay; Jennifer L Engle; Shubhada D Godbole; Jyothi M Noronha; Richard H Scheuermann; Liwei W Zhou; Christine Lion; Michael P Dempsey
Journal:  PLoS One       Date:  2009-09-16       Impact factor: 3.240

5.  Genomic deletion marking an emerging subclone of Francisella tularensis subsp. holarctica in France and the Iberian Peninsula.

Authors:  M P Dempsey; M Dobson; C Zhang; M Zhang; C Lion; C B Gutiérrez-Martín; P C Iwen; P D Fey; M E Olson; D Niemeyer; S Francesconi; R Crawford; M Stanley; J Rhodes; D M Wagner; A J Vogler; D Birdsell; P Keim; A Johansson; S H Hinrichs; A K Benson
Journal:  Appl Environ Microbiol       Date:  2007-09-21       Impact factor: 4.792

6.  Francisella tularensis peritonitis in stomach cancer patient.

Authors:  Xiang Y Han; Linus X Ho; Amar Safdar
Journal:  Emerg Infect Dis       Date:  2004-12       Impact factor: 6.883

7.  Isolation of Francisella tularensis and Yersinia pestis from Blood Cultures by Plasma Purification and Immunomagnetic Separation Accelerates Antibiotic Susceptibility Determination.

Authors:  Ronit Aloni-Grinstein; Ofir Schuster; Shmuel Yitzhaki; Moshe Aftalion; Sharon Maoz; Ida Steinberger-Levy; Raphael Ber
Journal:  Front Microbiol       Date:  2017-02-28       Impact factor: 5.640

8.  The Cynomolgus Macaque Natural History Model of Pneumonic Tularemia for Predicting Clinical Efficacy Under the Animal Rule.

Authors:  Tina Guina; Lynda L Lanning; Kristian S Omland; Mark S Williams; Larry A Wolfraim; Stephen P Heyse; Christopher R Houchens; Patrick Sanz; Judith A Hewitt
Journal:  Front Cell Infect Microbiol       Date:  2018-04-04       Impact factor: 5.293

9.  Rapid dissemination of Francisella tularensis and the effect of route of infection.

Authors:  Sandra S Ojeda; Zheng J Wang; Chris A Mares; Tingtung A Chang; Qun Li; Elizabeth G Morris; Paul A Jerabek; Judy M Teale
Journal:  BMC Microbiol       Date:  2008-12-09       Impact factor: 3.605

10.  Genetic Diversity and Spatial Segregation of Francisella tularensis Subspecies holarctica in Germany.

Authors:  Sandra Appelt; Kristin Köppen; Aleksandar Radonić; Oliver Drechsel; Daniela Jacob; Roland Grunow; Klaus Heuner
Journal:  Front Cell Infect Microbiol       Date:  2019-11-06       Impact factor: 5.293
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.